Your browser doesn't support javascript.
Long COVID occurrence in COVID-19 survivors.
Sugiyama, Aya; Miwata, Kei; Kitahara, Yoshihiro; Okimoto, Mafumi; Abe, Kanon; E, Bunthen; Ouoba, Serge; Akita, Tomoyuki; Tanimine, Naoki; Ohdan, Hideki; Kubo, Tatsuhiko; Nagasawa, Akira; Nakanishi, Toshio; Takafuta, Toshiro; Tanaka, Junko.
  • Sugiyama A; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Miwata K; Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan.
  • Kitahara Y; Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan.
  • Okimoto M; Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan.
  • Abe K; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • E B; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Ouoba S; Payment Certification Agency (PCA), Ministry of Health, Phnom Penh, Cambodia.
  • Akita T; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Tanimine N; Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Science de La Santé (IRSS), Nanoro, Burkina Faso.
  • Ohdan H; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Kubo T; Department of Gastroenterological and Transplantation Surgery, Hiroshima University, Hiroshima, Japan.
  • Nagasawa A; Department of Gastroenterological and Transplantation Surgery, Hiroshima University, Hiroshima, Japan.
  • Nakanishi T; Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Takafuta T; Miyoshi Central Hospital, Hiroshima, Japan.
  • Tanaka J; Miyoshi Central Hospital, Hiroshima, Japan.
Sci Rep ; 12(1): 6039, 2022 04 11.
Article in English | MEDLINE | ID: covidwho-1784030
ABSTRACT
This cross-sectional study aimed to investigate the post-acute consequences of COVID-19. We conducted a self-administered questionnaire survey on sequelae, psychological distress (K6), impairments in work performance (WFun), and COVID-19-related experiences of stigma and discrimination in two designated COVID-19 hospitals in Hiroshima Prefecture, Japan, between August 2020 and March 2021. The prevalence of sequelae was calculated by age and COVID-19 severity. Factors independently associated with sequelae or psychological distress were identified using logistic regression analysis. Among 127 patients who had recovered from COVID-19, 52.0% had persistent symptoms at a median of 29 days [IQR 23-128] after COVID-19 onset. Among patients with mild COVID-19, 49.5% had sequelae. The most frequent symptoms were olfactory disorders (15.0%), taste disorders (14.2%), and cough (14.2%). Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for ≥ 60 years vs. < 40 years 3.63, p = 0.0165). Possible psychological distress was noted in 30.7% (17.9% of males and 45.0% of females). Female sex and the presence of sequelae were independent risk factors for psychological distress. Of all participants, 29.1% had possible impairments in work performance. Experiences of stigma and discrimination were reported by 43.3% of participants. This study revealed the significant impacts of Long COVID on health in local communities. A large-scale, long-term cohort study is desired.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-022-10051-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-022-10051-z